We’re excited to share that we’ve recently made changes to our Medicare D actuarial valuation offerings by partnering with a new actuary, Lewis & Ellis (https://lewisellis.com/). Our collaboration with Lewis & Ellis is specifically designed for Medicare Part D valuations — now available at a competitive price.
These services maintain the high level of accuracy and compliance you’ve come to expect from us, while providing more flexibility and value to meet your budgetary needs.
Diversified Group will continue to use the CMS Simplified Method of valuation where applicable at no cost. However, since the Simplified Method does limit the allowed Rx deductible to a maximum of $250, HDHP’s cannot be valuated using this safe harbor method. In these cases, we have historically facilitated an actuarial valuation via a certified actuarial firm at a cost to the plan sponsor that is charged by that firm. In the past, we have used Milliman to undertake this testing. However, Milliman’s costs have increased prohibitively to a 2025 price of $5,000 per plan tested. Given this increase, Diversified Group undertook a search for a new actuarial partner to facilitate HDHP actuarial testing when desired.
If you’d like to learn more, please don’t hesitate to reach out to the Diversified compliance team. We’d be happy to walk you through the new options and discuss how they could benefit your organization.
Otherwise, we will be reaching out in the Fall to determine if there is interest in obtaining a Medicare D creditable coverage valuation on any of your plans.
Diversified’s Compliance Team:
Dave Follansbee – dfollansbee@diversifiedgb.com
Amber Defond – adefond@diversifiedgb.com
Laura Williams – lwilliams@diversifiedgb.com
Leave A Comment